The A-kinase anchoring proteins correlation with disease free survival in breast cancer

The A-kinase anchoring proteins correlation with disease free survival in breast cancer

Background: Researchers are always trying to find specific markers which express specifically in cancer. These specific markers help to diagnose and treat cancer without affecting normal tissues. Cancer-testis antigens are among the new promising biomarkers, especially for targeted therapy. These ma...

Full description

Bibliographic Details
Main Authors:	Rezvan Esmaeili, Tannaz Samadi, Nasrin Abdoli, Keivan Majidzadeh-Ardebili, Leila Farahmand, Malihe Salehi
Format:	Article
Language:	fas
Published:	Tehran University of Medical Sciences 2017-01-01
Series:	Tehran University Medical Journal
Subjects:	biomarkers breast cancer cancer-testis antigens disease-free survival
Online Access:	http://tumj.tums.ac.ir/browse.php?a_code=A-10-25-5523&slc_lang=en&sid=1

Similar Items

PIWIL2 and PL2L60 (Cancer/Testis genes) Expression in Breast Cancer
by: Rezvan Esmaeili, et al.
Published: (2014-11-01)

Expression of Multiple Cancer/Testis Genes in Several Breast Cancer Cell Lines
by: Shamseddin Yousef-Amoli, et al.
Published: (2014-04-01)

Sperm-Associated Antigen 9 as a Candidate Diagnostic and Prognostic Biomarker in Breast Cancer
by: Houra Naraghi, et al.
Published: (2020-10-01)

HNSCC: Tumour Antigens and Their Targeting by Immunotherapy
by: Adrian von Witzleben, et al.
Published: (2020-09-01)

Sperm Protein Antigen 17 Expression Correlates With Lymph Node Metastasis and Worse Overall Survival in Patients With Breast Cancer
by: Yu-ting Zhou, et al.
Published: (2019-07-01)

Corrigendum: Sperm Protein Antigen 17 Expression Correlates With Lymph Node Metastasis and Worse Overall Survival in Patients With Breast Cancer
by: Yu-ting Zhou, et al.
Published: (2020-06-01)

Urine exosome gene expression of cancer-testis antigens for prediction of bladder carcinoma
by: Yazarlou F, et al.
Published: (2018-11-01)

CANCER TESTIS ANTIGENS IN CANCER IMMUNOTHERAPY
by: D. I. Vodolazhsky, et al.
Published: (2017-06-01)

Cancer testis antigen and immunotherapy
by: Krishnadas DK, et al.
Published: (2013-04-01)

An overview of cancer/testis antigens expression in classical Hodgkin's lymphoma (cHL) identifies MAGE-A family and MAGE-C1 as the most frequently expressed antigens in a set of Brazilian cHL patients
by: Bortoluzzo Adriana B, et al.
Published: (2011-09-01)

The prevalence and expression pattern of melanoma-associated antigen 1 in esophageal squamous cell carcinoma: a historical cohort study
by: Kazem Anvari, et al.
Published: (2017-02-01)

Crosstalk between Stress Granules, Exosomes, Tumour Antigens, and Immune Cells: Significance for Cancer Immunity
by: Vinoth Kumar Kothandan, et al.
Published: (2020-04-01)

Cancer/testis antigens (CTAs) expression in resected lung cancer
by: Jin S, et al.
Published: (2018-08-01)

Functional and mechanistic studies reveal MAGEA3 as a pro-survival factor in pancreatic cancer cells
by: Biswajit Das, et al.
Published: (2019-07-01)

Cancer-Testis Antigens in Triple-Negative Breast Cancer: Role and Potential Utility in Clinical Practice
by: Runyi Adeline Lam, et al.
Published: (2021-07-01)

Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets
by: Kaipeng Xie, et al.
Published: (2019-01-01)

Establishment of cancer/testis antigen profiling based on clinicopathological characteristics in resected pathological stage III non-small cell lung cancer
by: Jin S, et al.
Published: (2018-07-01)

Serum gamma-glutamyltransferase and the overall survival of metastatic pancreatic cancer
by: Yuanyuan Xiao, et al.
Published: (2019-10-01)

EXPRESSION OF CANCER-TESTIS GENES PRAME, NY-ESO1, GAGE1, MAGE A3, MAGE A6, MAGE A12, SSX1, SLLP1, PASD1 IN PATIENTS WITH MULTIPLE MYELOMA, THEIR INFLUENCE ON OVERALL SURVIVAL AND RELAPSE RATE
by: A. A. Solodovnik, et al.
Published: (2018-07-01)

EFFECT OF ANTHRACYCLINE ANTITUMOR ANTIBIOTICS UPON TRANSCRIPTION ACTIVITY OF CANCER-TESTIS ANTIGENS IN MODEL EXPERIMENTS WITH HeLa CELLS
by: D. S. Kutilin, et al.
Published: (2019-07-01)

Frequency of cancer testis antigens in chronic myeloid leukemia
by: I. Mendoza-Salas, et al.
Published: (2016-04-01)

Upregulation of RHOXF2 and ODF4 Expression in Breast Cancer Tissues
by: Golnesa Kazemi-Oula, et al.
Published: (2015-10-01)

DNA hypomethylation drives changes in MAGE-A gene expression resulting in alteration of proliferative status of cells
by: Ashley Colemon, et al.
Published: (2020-07-01)

Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody
by: Saeed M, et al.
Published: (2016-03-01)

MAEL as a diagnostic marker for the early detection of esophageal squamous cell carcinoma
by: Mohammad Reza Abbaszadegan, et al.
Published: (2021-04-01)

Association of T Stage and Serum CEA Levels in Determining Survival of Rectal Cancer
by: Shengwen Wu, et al.
Published: (2020-01-01)

MAGE-A1 in lung adenocarcinoma as a promising target of chimeric antigen receptor T cells
by: Yuan Mao, et al.
Published: (2019-10-01)

EFFECT OF ANTHRACYCLINE ANTITUMOR ANTIBIOTICS UPON TRANSCRIPTION ACTIVITY OF CANCER-TESTIS ANTIGENS IN MODEL EXPERIMENTS WITH HELA CELLS
by: Denis Sergeevich Kutilin, et al.
Published: (2019-03-01)

Cancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACC
by: Mabrouka Doghman-Bouguerra, et al.
Published: (2020-03-01)

Cancer testis antigens in myelodysplastic syndromes revisited: a targeted RNA-seq approach
by: Ana María Hurtado López, et al.
Published: (2020-01-01)

Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis
by: Michael Lattanzi, et al.
Published: (2018-05-01)

Expression of tumor-associated antigens in breast cancer subtypes
by: Giuseppe Curigliano, et al.
Published: (2020-02-01)

Cancer Testis Antigens and Immunotherapy: Where Do We Stand in the Targeting of PRAME?
by: Ghaneya Al-Khadairi, et al.
Published: (2019-07-01)

Prostate-Associated Gene 4 (PAGE4): Leveraging the Conformational Dynamics of a Dancing Protein Cloud as a Therapeutic Target
by: Ravi Salgia, et al.
Published: (2018-06-01)

Characterization of the Survival Influential Genes in Carcinogenesis
by: Divya Sahu, et al.
Published: (2021-04-01)

TFRC and ACTB as the best reference genes to quantify Urokinase Plasminogen Activator in breast cancer
by: Abdoli Nasrin, et al.
Published: (2011-06-01)

ANALYSIS OF CANCER-TESTIS ANTIGENS AS POTENTIAL MARKERS FOR DISSEMINATION OF PRIMARY HUMAN SKIN MELANOMA
by: I. N. Mikhaylova, et al.
Published: (2021-06-01)

An in vivo genetic screen in Drosophila identifies the orthologue of human cancer/testis gene SPO11 among a network of targets to inhibit lethal(3)malignant brain tumour growth
by: Fabrizio Rossi, et al.
Published: (2017-01-01)

T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein
by: Laurent Julien, et al.
Published: (2013-01-01)

Expression of Cancer Testis Antigens in Tumor-Adjacent Normal Liver Is Associated with Post-Resection Recurrence of Hepatocellular Carcinoma
by: Lisanne Noordam, et al.
Published: (2021-05-01)